Atlas Trials

Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy

Clinical trial NCT05579847 · COMPLETED

Trial details

NCT number
NCT05579847
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Status
COMPLETED
Study type
OBSERVATIONAL
Renal Cell Carcinoma Stage IV
Start date
2022-10-19
Primary completion
2024-01-07
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.